198 related articles for article (PubMed ID: 17493059)
1. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
[TBL] [Abstract][Full Text] [Related]
2. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
[TBL] [Abstract][Full Text] [Related]
6. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
[TBL] [Abstract][Full Text] [Related]
7. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
8. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users.
Hillhouse MP; Marinelli-Casey P; Gonzales R; Ang A; Rawson RA;
Addiction; 2007 Apr; 102 Suppl 1():84-95. PubMed ID: 17493057
[TBL] [Abstract][Full Text] [Related]
9. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
Obert JL; Brown AH; Zweben J; Christian D; Delmhorst J; Minsky S; Morrisey P; Vandersloot D; Weiner A
J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
[TBL] [Abstract][Full Text] [Related]
10. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals.
Rawson RA; McCann MJ; Flammino F; Shoptaw S; Miotto K; Reiber C; Ling W
Addiction; 2006 Feb; 101(2):267-74. PubMed ID: 16445555
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
12. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
Roll JM
Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
[TBL] [Abstract][Full Text] [Related]
13. Coerced treatment for methamphetamine abuse: differential patient characteristics and outcomes.
Brecht ML; Anglin MD; Dylan M
Am J Drug Alcohol Abuse; 2005; 31(2):337-56. PubMed ID: 15912720
[TBL] [Abstract][Full Text] [Related]
14. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program.
Jaffe A; Shoptaw S; Stein J; Reback CJ; Rotheram-Fuller E
Exp Clin Psychopharmacol; 2007 Jun; 15(3):301-7. PubMed ID: 17563217
[TBL] [Abstract][Full Text] [Related]
15. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005.
Callaghan RC; Brands B; Taylor L; Lentz T
J Adolesc Health; 2007 Mar; 40(3):286-9. PubMed ID: 17321434
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes among women and men methamphetamine abusers in California.
Hser YI; Evans E; Huang YC
J Subst Abuse Treat; 2005 Jan; 28(1):77-85. PubMed ID: 15723735
[TBL] [Abstract][Full Text] [Related]
18. Integrating research and practice in the CSAT Methamphetamine Treatment Project.
Hamilton Brown A
J Subst Abuse Treat; 2004 Mar; 26(2):103-8. PubMed ID: 15050087
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
20. Treatments for methamphetamine abuse: a literature review for the clinician.
Brackins T; Brahm NC; Kissack JC
J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
